#1 HbA1c
Insulin Delivery Systems → HbA1c
Evidence Intelligence™
- EvidenceScore™
- 88
- Strong
- ImpactScore™
- 86
- Very Positive
- ConsistencyScore™
- 85
- consistent
Estudios de apoyo: Basado en 21 estudios
Explore evidenceDevices & Technology
Last updated: 12 de septiembre de 2026
Key takeaway
Devices & Technology has evidence across 10 diabetes-related outcomes, with strongest support for HbA1c, CGM Time in Range and Hypoglycemia.
Evidence status
Moderate ResearchEvidence Strength: 61/100
Related Evidence Topics
Evidence Intelligence™
Every evidence topic is generated from structured relationships across diabetes research, including topics, interventions, outcomes, and individual studies.
571
Evidence relationships
714
Studies reviewed
26
Outcomes evaluated
Strongest evidence area
HbA1c
Top Interventions
Showing grouped evidence. Expand in Evidence Explorer for detailed intervention-outcome pairs.Open Evidence Explorer
| Rank | Outcome group | EvidenceScore™ | ImpactScore™ | Consistency | Studies | Effectiveness | Action |
|---|---|---|---|---|---|---|---|
| #1 | HbA1c | 88/100Strong | 86/100Very Positive | 85/100consistent | 21 | strong_positive | Explore evidence |
| #2 | CGM Time in Range | 88/100Strong | 72/100Positive | 57/100generally_consistent | 38 | moderate_positive | Explore evidence |
| #3 | Hypoglycemia | 86/100Strong | 56/100Slightly Positive | 56/100generally_consistent | 9 | weak_positive | Explore evidence |
| #4 | Quality of Life Outcomes | 86/100Strong | 64/100Slightly Positive | 35/100mixed | 9 | weak_positive | Explore evidence |
| #5 | Fasting Glucose | 85/100Strong | 72/100Positive | 78/100consistent | 9 | moderate_positive | Explore evidence |
| #6 | Glucose Variability | 85/100Strong | 63/100Slightly Positive | 63/100generally_consistent | 8 | weak_positive | Explore evidence |
| #7 | Fasting Glucose | 84/100Strong | 70/100Positive | 60/100generally_consistent | 5 | moderate_positive | Explore evidence |
| #8 | Body Mass Index | 84/100Strong | 80/100Positive | 60/100generally_consistent | 5 | moderate_positive | Explore evidence |
| #9 | Body Weight | 83/100Strong | 100/100Very Positive | 100/100consistent | 7 | strong_positive | Explore evidence |
| #10 | HbA1c | 83/100Strong | 100/100Very Positive | 100/100consistent | 6 | strong_positive | Explore evidence |
#2 CGM Time in Range
Insulin Delivery Systems → CGM Time in Range
Evidence Intelligence™
- EvidenceScore™
- 88
- Strong
- ImpactScore™
- 72
- Positive
- ConsistencyScore™
- 57
- generally_consistent
Estudios de apoyo: Basado en 38 estudios
Explore evidence#3 Hypoglycemia
Insulin Delivery Systems → Hypoglycemia
Evidence Intelligence™
- EvidenceScore™
- 86
- Strong
- ImpactScore™
- 56
- Slightly Positive
- ConsistencyScore™
- 56
- generally_consistent
Estudios de apoyo: Basado en 9 estudios
Explore evidence#4 Quality of Life Outcomes
Insulin Delivery Systems → Quality of Life Outcomes
Evidence Intelligence™
- EvidenceScore™
- 86
- Strong
- ImpactScore™
- 64
- Slightly Positive
- ConsistencyScore™
- 35
- mixed
Estudios de apoyo: Basado en 9 estudios
Explore evidence#5 Fasting Glucose
Insulin Delivery Systems → Fasting Glucose
Evidence Intelligence™
- EvidenceScore™
- 85
- Strong
- ImpactScore™
- 72
- Positive
- ConsistencyScore™
- 78
- consistent
Estudios de apoyo: Basado en 9 estudios
Explore evidence#6 Glucose Variability
Insulin Delivery Systems → Glucose Variability
Evidence Intelligence™
- EvidenceScore™
- 85
- Strong
- ImpactScore™
- 63
- Slightly Positive
- ConsistencyScore™
- 63
- generally_consistent
Estudios de apoyo: Basado en 8 estudios
Explore evidence#7 Fasting Glucose
Digital Lifestyle Interventions → Fasting Glucose
Evidence Intelligence™
- EvidenceScore™
- 84
- Strong
- ImpactScore™
- 70
- Positive
- ConsistencyScore™
- 60
- generally_consistent
Estudios de apoyo: Basado en 5 estudios
Explore evidence#8 Body Mass Index
Digital Lifestyle Interventions → Body Mass Index
Evidence Intelligence™
- EvidenceScore™
- 84
- Strong
- ImpactScore™
- 80
- Positive
- ConsistencyScore™
- 60
- generally_consistent
Estudios de apoyo: Basado en 5 estudios
Explore evidence#9 Body Weight
Digital Lifestyle Interventions → Body Weight
Evidence Intelligence™
- EvidenceScore™
- 83
- Strong
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- 100
- consistent
Estudios de apoyo: Basado en 7 estudios
Explore evidence#10 HbA1c
Digital Lifestyle Interventions → HbA1c
Evidence Intelligence™
- EvidenceScore™
- 83
- Strong
- ImpactScore™
- 100
- Very Positive
- ConsistencyScore™
- 100
- consistent
Estudios de apoyo: Basado en 6 estudios
Explore evidencePractical Questions
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
Which outcomes have the strongest evidence for Devices & Technology?
evidence strengthStrong Evidence
HbA1c and Time in range have the strongest available evidence signals for Devices & Technology.
ConsistencyScore™: Results are generally consistent across studies.
Ranked evidence signals
- 1
Time in range
EvidenceScore™ Strong | EvidenceScore™ 87.7 | moderate positive | ConsistencyScore™ Generally Consistent | 35 studies
- 2
HbA1c
EvidenceScore™ Strong | EvidenceScore™ 85.5 | moderate positive | ConsistencyScore™ Consistent | 13 studies
Why this answer: This answer is based on 40 supporting studies with generally consistent results and a positive effect signal.
What outcomes does Devices & Technology appear to affect most often?
most studiedEmerging Evidence
HbA1c, Blood glucose, and Time in range are among the most studied areas in relation to Devices & Technology.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Time in range
EvidenceScore™ Strong | EvidenceScore™ 87.7 | moderate positive | ConsistencyScore™ Generally Consistent | 47 studies
- 2
HbA1c
EvidenceScore™ Strong | EvidenceScore™ 86.2 | strong positive | ConsistencyScore™ Consistent | 54 studies
- 3
Blood glucose
EvidenceScore™ Strong | EvidenceScore™ 79.0 | moderate positive | ConsistencyScore™ Consistent | 16 studies
Why this answer: This answer is based on 90 supporting studies and existing graph evidence signals.
Where are results mixed or inconsistent for Devices & Technology?
consistency issuesModerate Evidence
Results are mixed or unclear for Body weight, Pre-meal mean glucose, and Sleep efficiency in relation to Devices & Technology.
ConsistencyScore™: Results are mixed and should be interpreted cautiously.
Evidence caveat: The evidence includes both beneficial and harmful or worsening results.
Ranked evidence signals
- 1
Time above range
EvidenceScore™ Strong | EvidenceScore™ 82.7 | weak positive | ConsistencyScore™ Mixed | 7 studies
- 2
HbA1c
EvidenceScore™ Strong | EvidenceScore™ 79.0 | moderate positive | ConsistencyScore™ Mixed | 6 studies
- 3
Sleep quality
EvidenceScore™ Strong | EvidenceScore™ 79.0 | weak positive | ConsistencyScore™ Mixed | 5 studies
Why this answer: This answer is cautious because the available studies report mixed findings.
Which outcomes need more research for Devices & Technology?
research gapsEmerging Evidence
Body weight, HbA1c, and Health-related quality of life need more research in relation to Devices & Technology.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Body weight
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
- 2
HbA1c
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
- 3
Health-related quality of life
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a small number of supporting studies and should be interpreted cautiously.
Limitations
- Only a small number of supporting studies are available.
How does Time in range compare with Time in range for Devices & Technology?
compareStrong Evidence
Time in range have available evidence for Devices & Technology, but the comparison requires review of the underlying studies.
ConsistencyScore™: Results are generally consistent across studies.
Ranked evidence signals
- 1
Time in range
EvidenceScore™ Strong | EvidenceScore™ 87.7 | moderate positive | ConsistencyScore™ Generally Consistent | 35 studies
Why this answer: This answer is based on 35 supporting studies with generally consistent results and a positive effect signal.
Outcomes Influenced by Devices & Technology
Outcomes most commonly studied in relation to devices & technology interventions.
Diabetes Distress
EvidenceScore™ 64/100
Evidence related to Diabetes Distress.
9 Studies
Glycemic Control
EvidenceScore™ 63/100
Evidence related to blood glucose control, fasting glucose, postprandial glucose, glucose variability, and time in range.
117 Studies
HbA1c Reduction
EvidenceScore™ 63/100
Evidence related to lowering or improving HbA1c/A1C in diabetes management.
65 Studies
Glucose Variability
EvidenceScore™ 62/100
Evidence related to Glucose Variability.
9 Studies
CGM Time in Range
EvidenceScore™ 62/100
Evidence related to CGM Time in Range.
18 Studies
Weight Loss
EvidenceScore™ 62/100
Evidence related to body weight reduction, BMI improvement, waist circumference, and body composition changes.
32 Studies
Latest Research
Hybrid closed-loop system improves glycemic control in neonatal diabetes.
Published: 24 de febrero de 2026
int-hybrid-closed-loop-system
out-average-glucoseout-glucose-variability
Artificial pancreas may improve glucose control in type 1 diabetes
Published: 20 de enero de 2026
int-hybrid-closed-loop-system
out-blood-glucoseout-hypoglycemia-events
Caloric restriction improves glycemic control
Published: 1 de enero de 2026
int-continuous-glucose-monitoring
out-2-hour-plasma-glucoseout-bmi
Automated insulin-glucagon delivery reduces hypoglycemia risk
Published: 1 de enero de 2026
int-hybrid-closed-loop-system
out-blood-glucoseout-coefficient-of-variation
Daqing Diabetes Prevention Study II
Published: 1 de enero de 2026
int-digital-based-lifestyle-intervention
out-blood-glucoseout-bmi
Smart insulin software improves glycemic control in T2DM patients.
Published: 1 de enero de 2026
int-smart-insulin-dosage-software-app-group
out-blood-glucoseout-glycemia-risk-index
Automated insulin delivery improves glucose management in diabetes with CKD
Published: 1 de enero de 2026
int-continuous-glucose-monitoringint-hybrid-closed-loop-system
out-hospitalization-rateout-hypoglycemia-symptom-score
Early meal timing improves nocturnal glucose levels.
Published: 1 de enero de 2026
int-continuous-glucose-monitoring
out-2-hour-plasma-glucoseout-diurnal-mean-glucose
Education Model Improves Glycemic Control in Type 1 Diabetes
Published: 1 de enero de 2026
int-continuous-glucose-monitoring
out-clarke-scoreout-hba1c
Increased blue light exposure worsens glycemic control in type 1 diabetes.
Published: 1 de enero de 2026
int-dim-light-exposure
out-anxiety-scoreout-depressive-symptoms-prevalence
Evidence Landscape
Evidence landscape
Each bubble represents an evidence relationship. Position shows effectiveness and EvidenceScoreâ„¢; size reflects study volume.
- Strong evidence
- Moderate evidence
- Limited evidence
Evidence Workspace
Create your evidence workspace
Save evidence topics and organize the research that matters to you.